KALARIS THERAPEUTICS, INC. Operating Lease, Liability, Current
KALARIS THERAPEUTICS, INC. (KLRS) had Operating Lease, Liability, Current of $347.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-11
- 2026-06-30: Operating Lease, Liability, Current $347.00K.
- 2026-03-31: Operating Lease, Liability, Current $317.00K.
- 2025-12-31: Operating Lease, Liability, Current $316.00K.
- 2025-09-30: Operating Lease, Liability, Current $376.00K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-06-30 | $347.00K 10-Q · filed 2026-08-11 |
| 2026-03-31 | $317.00K 10-Q · filed 2026-05-12 |
| 2025-12-31 | $316.00K 10-Q · filed 2026-08-11 |
| 2025-09-30 | $376.00K 10-Q · filed 2025-11-12 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-17 |
| 2024-06-30 | $667.00K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $2.29M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $10.78M 10-K · filed 2025-03-07 |
| 2023-09-30 | $12.98M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $8.48M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $8.27M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $7.17M 10-K · filed 2024-03-15 |
| 2022-09-30 | $1.92M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $2.24M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $2.36M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $6.59M 10-K · filed 2023-02-15 |
| 2021-09-30 | $6.30M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $4.83M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $4.79M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $3.23M 10-K · filed 2022-02-10 |
| 2020-09-30 | $3.19M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $3.15M 10-Q · filed 2020-09-02 |
| 2019-12-31 | $3.07M 10-K · filed 2021-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |